Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
You are here: Home Protocols BRSCW Application: Lokshin - Univ of Pitts (2008)

BRSCW Application: Lokshin - Univ of Pitts (2008)

288
TgII, SCC, HSP 70, IGFBP-1,2, GH, sICAM-1, MMP-9, MPO, tPAI-1, CA72-4, CA15-3, EGFR, Osteopontin (OPN), Endostatin (RNDO), Thrombospondin (THBS), Angiostatin (ANGIO), Apolipoproteins (Apo) A1, A2, B, E), Resistin, and PAI-1
Case/control
Proteomics
Breast and Gynecologic Cancers Research

One KLK,(KLK6) ranked 6th among all tested biomarkers(approx.50)


One KLK,(KLK6) ranked 6th among all tested biomarkers(approx.50)
1.   Validation of ovarian cancer biomarkers (pre- and post-menopausal women) 2.   Validation of breast cancer biomarkers
Luminex

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.